Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2023-11-10
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will complete the following:
* hearing tests
* cognitive and behavioral measures
* questionnaires about their symptoms
* both passive and active hearing tasks while brain activity is recorded with a neuroimaging cap Results will be compared between individuals with autism with and without Fragile X Syndrome as well as individuals without autism.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain and Eye Markers of Facial Expression Recognition and Disorders Associated with Autistic Symptoms
NCT05635812
Left and Right Hemisphere Contributions to Speech Perception
NCT04989309
Study of Brain Activity During Speech Production and Speech Perception
NCT00004991
Oxytocin Effect on Attentional Bias Towards Emotional Expression Faces in Individuals With High and Low Autistic Traits: A Functional Magnetic Resonance Imaging (fMRI) Study
NCT02741063
Dopamine and Sensorimotor Function in Stuttering
NCT07215884
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recruitment Strategy is through email and social media ads, contacting previous study participants who have consented to contact about future studies, and through local and national organizations and foundations, including the National Fragile X Foundation.
Hearing measures will include 1) behavioral audiometry presented via calibrated earphones 2) Otoacoustic Emissions (OAEs) between 2000-8000 Hz. The investigators will use two tasks to measure speech-in-noise perception. The 3) Digits-In-Noise task (DIN) requires participants to repeat single digits spoken in background noise. The loudness of the spoken digits then varies adaptively based on the participant's performance, and a Speech Reception Threshold (SRT) is calculated. The SRT indicates the ratio of speech to noise level in dB at which the participant correctly reports the digit 50% of the time. The investigators will use a variation of the DIN that includes both interaural "in-phase" (Diotic) and "out-of-phase" (Antiphasic) presentation, which allows for characterization of temporal fine structure perception.
The second speech-in-noise task is the 4) Auditory Attention subtest of the Woodcock Johnson III. This task requires no verbal output; instead participants touch or point to the picture of a word that they hear. Background noise is varied, and the individual's ability to correctly identify the word at different speech-to-noise ratios is recorded. The outcome variables for this test include both a raw score of number correct over a range of speech-to-noise ratios and an age-normed standard score. The investigators are using tests that minimize verbal requirements for two reasons. First, this will allow for inclusion of more participants rather than excluding those with cognitive impairment. Second, by minimizing contributions of working memory required for digit strings and use of context clues (as can occur with sentences in noise), the investigators are able to focus on true differences between groups in speech-in-noise perception.
Finally, the investigators will use an audiovisual DIN task where single digit stimuli are paired with the dynamic oval stimulus used in the neuroimaging paradigm to determine behavioral effects of adding a visual stimulus.
Behavioral measures will include standardized assessments of sensory symptoms and experiences (Sensory Profile, Sensory Experiences Questionnaire, Sensory Perception Quotient \[33\]), social communication symptoms (Autism Spectrum Quotient, Social Responsiveness Scale), restrictive/ repetitive behavior symptoms (Repetitive Behaviors Questionnaire-2 and Adult Repetitive Behaviours Questionnaire-2 \[34\]), verbal and nonverbal cognitive abilities (Stanford Binet V), and handedness (Purdue Pegboard task, Edinburgh Handedness Inventory). Most of these measures have both a self-report and parent-report option, use of both of which will enable the investigators to get data from participants with a wide range of abilities. They are also normed on both adolescent and adult samples.
Physiological stimuli: Speech stimuli include repeated consonant-vowel syllables presented within an oddball/mismatch negativity (MMN) paradigm that includes frequent, standard syllables and infrequent deviant syllables. Noise stimuli is "babble" noise (speech-like but unintelligible).
Paradigm: The investigators will use two types of neuroimaging within one cap to measure brain activity: 1) functional Near Infrared Spectroscopy (fNIRS) uses light delivered and measured at particular frequencies on the scalp to determine changes in oxygenation of hemoglobin on the cortical surface and 2) Event Related Potentials (ERP) records changes in voltage on the surface of the scalp in relation to changes in stimulus presentation. The investigators will compare brain activity between four conditions: 1) speech alone 2) noise alone 3) speech in noise and 4) speech in noise with a Dynamic Oval. Stimuli will be presented in short trials (ERP) embedded in longer blocks (fNIRS). Specifically, repeated standard and deviant syllables will be presented constantly for 15 seconds followed by 13-17 seconds of jittered rest. This allows the investigators to measure the blood oxygen level dependent (BOLD) response over the 30 second block (fNIRS) while measuring ERPs to deviant stimuli within those blocks. The investigators will also present speech embedded in noise with an animated oval that expands and contracts with the amplitude of the consonant-vowel sounds to determine effects of a non-social visual cue on hearing perception.
Neuroimaging: Integrated 32-channel gel-based EEG and 30 channel fNIRS system with standard 10-20 placement. EEG variables will include MMN amplitude and latency in response to deviant syllables, event-related power during the noise and speech conditions, and resting state oscillations. fNIRS variables will include lateralization and amplitude of neural response to speech and noise in both auditory and executive functioning regions of interest. Similar to speech-in-noise studies with fMRI, the investigators will compare speech alone, noise alone, and speech in noise to map cortical activity during speech-in-noise processing \[38\].
After completing phone-based consent/assent/permission, participants and their guardians (as needed) will complete an interview over the phone including administration of the Vineland Adaptive Behavior Scales and a brief review of medical and behavioral history. They will also receive a packet in the mail with forms to be completed prior to the in-person visit, which can be mailed back with a pre-stamped and addressed envelope or brought to the study visit and completed there. These forms will include 1) Sensory processing measures (Sensory Profile, Sensory Experiences Questionnaire, Sensory Perception Quotient) 4) Social Communication measures (Autism Spectrum Quotient, Social Responsiveness Scale) and Restrictive/Repetitive behavior assessment (Repetitive3 Behaviors Questionnaire, Adult Repetitive Behaviors Questionaire). All data collected prior to the study visit will be labeled with a subject ID number and will include the participant's date of birth. Study ID's are linked to each participant's name in a single, password protected database that is only accessible by the study PI and other persons approved by the institutional review board for this specific study.
During the in-person study visit, participants and/or parents will review the consent/assent/permission forms prior to beginning study procedures. Participants will then complete hearing measures, including hearing thresholds, otoacoustic emissions, digits-in-noise perception, and the Auditory Attention task. They will also complete a measure of cognitive abilities (Stanford-Binet 5th edition) and may complete the Autism Diagnostic Observation Schedule as needed for confirmation of diagnostic status.
Finally, participants will complete the cortical speech-in-noise perception paradigm. To complete this paradigm, participants will wear an elastic cap that is individually-sized based on head circumference (ActiCap outfitted with NIRX laser sources and detectors in addition to 32 channel EEG). Electrodes are gel-based, and gel will be applied prior to cap application or after cap placement depending on participant comfort. While measuring head circumference, a small amount of electrode gel will be placed on the forearm to ensure that the participant does not display skin sensitivities. Once it is determined that no sensitivities are present, the cap will be placed, with additional gel application as needed to reduce impedance; preapplication of gel reduces cap placement time. Once the cap is placed, sound stimuli will be presented via speakers on either side of a computer monitor, while non-social videos are played to maintain attention. Sound stimuli include short speech sounds (/ba/,/da/) and background babble noise. These will occur in block format, with blocks lasting 15 seconds and jitter of 13-17 seconds between blocks. Within the blocks with speech sounds, the sounds will change between consonants ba and da in order to capture neural responses to sound change. The total paradigm is 25 minutes, but participants will be able to stop at any time prior to that timepoint. Data collected during the neuroimaging protocol includes 1) a video of the cap placement to be used for photometric optode localization 2) video of the participant to be used later to exclude any trials with clear movement and 3) collection of hemodynamic and electrophysiological data from the brain. Videos used for photometric optode localization and trial exclusion will be labelled by subject ID and stored in a password protected folder in a drive that is only accessible to IRB-approved study personnel. Hemodynamic and electrophysiological data will be labelled with the subject ID and stored on the acquisition computer, which is also password protected, prior to data analysis.
Participants will then complete the audiovisual condition while they continue to wear the fNIRS/EEG cap. In this condition, participants will hear sounds as described above but will also see a shape on the computer screen that moves. The shape will be a black filled oval on a white background, with height of the oval varying similarly to sound intensity such that it is temporally aligned with vowel onset. There is no behavioral task for this measure. The investigators will use videos collected during the task to determine if the participant is looking at the screen or away prior to analysis of brain activity data.
Data will only be accessed by study personnel approved by the CCHMC IRB for those specific studies, and will be provided to the PI for this study as per data sharing agreements including participant consent for data sharing. After data is labelled with the study ID for the present study, it will not be linked to the participant's name.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Speech Sounds
Participants will hear repeated speech sounds while wearing a neuroimaging cap.
Mismatch negativity
Event related potentials are compared between frequent and infrequent speech sounds (i.e., "ba" vs "da").
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mismatch negativity
Event related potentials are compared between frequent and infrequent speech sounds (i.e., "ba" vs "da").
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. corrected 20/20 vision (Snellen chart)
3. no history of premature birth (prior to 36 weeks gestation)
4. no medications known to affect EEG signal
5. English as the first language
Inclusion for the Autism group requires the following:
1\) diagnosis of Autism Spectrum Disorder either based on previous ADOS administration and developmental history, or confirmed via ADOS and developmental history
Inclusion for the Autism + FXS group requires the following:
1. Documented PCR/Southern Blot genetic testing confirming full mutation FXS
2. Diagnosis of Autism Spectrum Disorder, per Autism group.
Inclusion for the Typically Developing group requires the following:
1. no siblings or parents with an Autism Spectrum Disorder or Fragile X Syndrome
2. no current neurological or psychiatric diagnoses
3. IQ over 75
Exclusion Criteria
* history of premature birth (prior to 36 weeks gestation)
15 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Medical Center, Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth Smith, PhD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-0532
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.